News

Pharmabiz54m
Johnson & Johnson announces new data from Tremfya phase 3 QUASAR LTE study in adults with moderately-to-severely active ulcerative colitis
Johnson & Johnson announces new data from Tremfya phase 3 QUASAR LTE study in adults with moderately-to-severely active ulcerative colitis: San Diego, California Tuesday, May 6, 2 ...
Pharmabiz1h
Neurocrine Biosciences announces new survey revealing need for routine screening and earlier diagnosis for people living with tardive dyskinesia
Neurocrine Biosciences announces new survey revealing need for routine screening and earlier diagnosis for people living with tardive dyskinesia: San Diego Tuesday, May 6, 2025, 1 ...
Pharmabiz2h
Novavax announces significantly improved terms for collaboration and license pact with Takeda for Nuvaxovid in Japan
Novavax announces significantly improved terms for collaboration and license pact with Takeda for Nuvaxovid in Japan: Gaithersburg, Maryland Tuesday, May 6, 2025, 14:00 Hrs [IST] ...
Pharmabiz3h
Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting
Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting: Atlanta Tuesday, May 6, 2025, 13:00 Hrs [IST] Artivion, Inc., a leading cardiac ...
Pharmabiz4h
Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM
Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM: Our Bureau, Mumbai Tuesday, May 6, 2025, 12:50 Hrs ...
Pharmabiz4h
Fujifilm India set up ‘Fujifilm Skill Club’ transforming healthcare with knowledge, collaboration, and resources
Fujifilm India set up ‘Fujifilm Skill Club’ transforming healthcare with knowledge, collaboration, and resources: Our Bureau, Bengaluru Tuesday, May 6, 2025, 12:40 Hrs [IST] F ...
Pharmabiz4h
IBA introduces QUASAR GRID3D Advantage Image Distortion Analysis System at ESTRO 2025 Congress
IBA introduces QUASAR GRID3D Advantage Image Distortion Analysis System at ESTRO 2025 Congress: Louvain-la-Neuve, Belgium Tuesday, May 6, 2025, 12:00 Hrs [IST] IBA (Ion Beam Appli ...
Pharmabiz5h
Senores Pharma acquires US FDA approved ANDA for epilepsy & migraine drug, topiramate HCl 25, 50, 100 and 200 mg tablets from Wockhardt
Senores Pharma acquires US FDA approved ANDA for epilepsy & migraine drug, topiramate HCl 25, 50, 100 and 200 mg tablets from Wockhardt: Our Bureau, New Delhi Tuesday, May 6, 2025 ...
Pharmabiz5h
Glenmark's cancer drug ISB 2001 gets fast track designation from US FDA
Glenmark's cancer drug ISB 2001 gets fast track designation from US FDA: Our Bureau, New Delhi Tuesday, May 6, 2025, 11:15 Hrs [IST] New York-based Ichnos Glenmark Innovation (IGI ...
Pharmabiz5h
Nanobiotix announces full results from completed phase 1 study evaluating JNJ-1900 (NBTXR3) in pancreatic cancer
Nanobiotix announces full results from completed phase 1 study evaluating JNJ-1900 (NBTXR3) in pancreatic cancer: Paris Tuesday, May 6, 2025, 11:00 Hrs [IST] Nanobiotix, a late-st ...
Pharmabiz6h
Veraxa Biotech inks co-discovery alliance with OmniAb for novel bispecific ADC programme
Veraxa Biotech inks co-discovery alliance with OmniAb for novel bispecific ADC programme: Zurich, Switzerland Tuesday, May 6, 2025, 10:00 Hrs [IST] Veraxa Biotech AG (Veraxa), an ...
Pharmabiz7h
Dianthus Therapeutics completes patient enrollment in phase 2 MaGic trial of DNTH103 in generalized myasthenia gravis
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, announced ...